INDIANAPOLIS, Feb. 15, 2016 -- PTS Diagnostics, the U.S.-based manufacturer of point-of-care biometric testing devices such as the CardioChek® family of analyzers, A1CNow® systems, and PTS Detect™ cotinine systems, has renewed its multi-year agreement with Life Line Screening to provide the CardioChek family of lipid and glucose testing products for Life Line Screening’s use across the country.
Life Line Screening, the nation’s largest provider of direct-to-consumer preventive health screenings, will begin using the CardioChek Plus analyzer allowing simultaneous testing of lipids and glucose with a single fingerstick in the first quarter of 2016.
Over the past several years, Life Line Screening used the CardioChek PA analyzer to significantly increase the number of health screenings the company performed. During this time period, Life Line Screening expanded into several additional states.
“CardioChek analyzers have helped us provide superior quality and customer service to our health screening participants,” said Sara Zywicki, Life Line Screening's Vice President of Clinical and Product Management. “Their system is accurate and easy to use. It doesn't require refrigeration and is battery-operated, which are important operational benefits for our teams. We have become a more efficient organization thanks to the use of the CardioChek system. The upgrade to the CardioChek Plus analyzer should help us become even more efficient in 2016.”
Joe Gonzalez, President of Hanson Medical Systems, commented that Life Line Screening’s experience with PTS Diagnostics’ education, training, and technical support has been excellent. “Life Line Screening has had a very good track record with the CardioChek systems by PTS Diagnostics. At Hanson, we understand that the CardioChek systems have helped Life Line Screening grow their business, and PTS Diagnostics provides superior service to their customers,” said Gonzalez. “Hanson is very proud to participate in Life Line Screening’s success.”
Robert Huffstodt, President and CEO of PTS Diagnostics, said the CardioChek family of products continues to grow in popularity among wellness and biometric screening companies.
“Life Line Screening has taken full advantage of the CardioChek analyzer’s proven accuracy, speed, reliability, and efficiency,” said Huffstodt. “This is exactly the type of story we at PTS Diagnostics love to share. They are a model customer.”
The CardioChek Plus analyzer, a cost-efficient, user-friendly diagnostic point-of-care device, provides rapid on-site lipid panel plus glucose screenings. The capability to deliver both results in as little as 90 seconds enables healthcare professionals to screen more individuals faster. Offering simultaneous testing of a lipid profile (total cholesterol, HDL cholesterol, triglycerides) and glucose, the CardioChek Plus analyzer also calculates LDL cholesterol, total cholesterol/HDL cholesterol ratio, LDL cholesterol/HDL cholesterol ratio, and non-HDL cholesterol. The CardioChek Plus device requires only a small blood sample from a fingerstick.
About Life Line Screening
Life Line Screening was established in 1993, and has since become the nation's leading provider of preventive health screenings. Highly trained clinical teams are on staff across the nation to bring affordable screenings to convenient, neighborhood locations. These non-invasive, painless tests help people identify their risk for stroke, vascular diseases or osteoporosis early enough that they and their physicians can begin preventive procedures. Visit the website at www.lifelinescreening.com or call 1-800-694-9721.
About PTS Diagnostics
PTS Diagnostics is an innovative, global, point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company’s name represents the three pillars upon which it has built its long-term success: People, Technology and Service. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, distributes and markets products for distribution in more than 135 countries around the world. For more information, visit www.ptsdiagnostics.com or contact Tom Wiser at 317-870-5610 or [email protected].
About Hanson Medical Systems Inc.
Since 1984, Hanson Medical Systems, Inc. has been a specialty distributor and consultant for point-of-care CLIA-waived medical equipment for wellness and health screening and worksite health. They have become a trusted partner for health screeners, occupational-corporate medical, health promotion, wellness, military, government, and other healthcare providers. For more information about Hanson Medical Systems, visit www.hansonmed.com or call 877-671-3883.
Contact: J. Thomas Wiser 317-517-2216


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 



